News|Articles|November 17, 2026

White House pulls Overton FDA nomination, Marshall might be nominated instead

Listen
0:00 / 0:00

Key Takeaways

  • Withdrawal of Heidi Overton’s nomination perpetuates commissioner-level instability at FDA, with acting leadership continuing since May 2026 under Kyle Diamantas.
  • Focus has moved to Sen. Roger Marshall, an OB-GYN and MAHA caucus chair, leveraging Senate relationships that can streamline confirmation dynamics.
SHOW MORE

Heidi Overton ran into opposition from Republican senators concerned about her role in setting White House vaccine policy.

Numerous news outlets, starting with Axios, are reporting that the White House has decided to pull the nomination of Heidi Overton to lead the FDA.

Semafor reported Tuesday that Sen. Roger Marshall might be nominated instead. Marshall, a Kansas Republican, lost his reelection amid the blue wave that swept many Republicans from office. Marshall is chair of the Senate’s Make America Healthy Again (MAHA) caucus.

The FDA has been without a commissioner since May 2026, when Marty Markary resigned under pressure. Kyle Diamantas has been the acting commissioner since.

Overton’s nomination had come under attack from a variety of interests and politicians. The Senate Health, Education, Labor and Pensions Committee had been scheduled to vote on her nomination tomorrow. The current chair of the committee, Sen. Bill Cassidy, a lame duck Republican senator, has expressed reservations about Overton because of his role in drafting an executive order issued in August 2026 that calls for recategorizing childhood vaccines so some are recommended only for high-risk groups and others, including vaccines against COVID-19 and hepatitis A and B, are left to shared decision-making between parents and clinicians.

Overton has also been criticized by MAHA activists for being too close to industry and by some anti-abortions for not doing more to restrict access to the abortion pill.

Marshall was a practicing obstetrician-gynecologist before entering politics. Senators often have an easier time getting confirmed for executive branch positions because of their Senate connections. Despite his leadership role at MAHA in the Senate, Marshall may face opposition from some elements of the movement because he hasn’t supported bans on the herbicide glyphosate.

This is a developing story.


Related to this article